YME1L1 and acute kidney injury: This study is the first to identify the YME1L1 as a target of SREBP1c, elucidating a SREBP1c/YME1L1 axis in response to cisplatin‐induced maladaptive repair of renal tubules in AKI, thus offering novel insights into the pathogenesis of AKI.